349 related articles for article (PubMed ID: 32908938)
1. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Berberine on the Insulin Resistance and TLR4/IKKbeta/NF-kappaB Signaling Pathways in Skeletal Muscle of Obese Rats with Insulin Resistance].
Zhang DS; Bai XH; Yao YJ; Mu DZ; Chen J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):827-31. PubMed ID: 26867315
[TBL] [Abstract][Full Text] [Related]
3. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells.
Li F; Zhao YB; Wang DK; Zou X; Fang K; Wang KF
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):64-69. PubMed ID: 26838742
[TBL] [Abstract][Full Text] [Related]
4. Berberine Ameliorates Insulin Resistance by Inhibiting IKK/NF-κB, JNK, and IRS-1/AKT Signaling Pathway in Liver of Gestational Diabetes Mellitus Rats.
Li A; Lin C; Xie F; Jin M; Lin F
Metab Syndr Relat Disord; 2022 Oct; 20(8):480-488. PubMed ID: 35862014
[No Abstract] [Full Text] [Related]
5. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
6. [Study on effect of gypenosides on insulin sensitivity of rats with diabetes mellitus via regulating NF-κB signaling pathway].
Zhu KN; Tian SS; Wang H; Tian YS; Gu GZ; Qiu YY; Zhang L; Yang HX
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4488-4496. PubMed ID: 34581054
[TBL] [Abstract][Full Text] [Related]
7. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.
Chang W; Zhang M; Li J; Meng Z; Wei S; Du H; Chen L; Hatch GM
Metabolism; 2013 Aug; 62(8):1159-67. PubMed ID: 23537779
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
9. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
[TBL] [Abstract][Full Text] [Related]
10. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
[TBL] [Abstract][Full Text] [Related]
11. Caffeic Acid Phenethyl Ester (Propolis Extract) Ameliorates Insulin Resistance by Inhibiting JNK and NF-κB Inflammatory Pathways in Diabetic Mice and HepG2 Cell Models.
Nie J; Chang Y; Li Y; Zhou Y; Qin J; Sun Z; Li H
J Agric Food Chem; 2017 Oct; 65(41):9041-9053. PubMed ID: 28799756
[TBL] [Abstract][Full Text] [Related]
12. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
[TBL] [Abstract][Full Text] [Related]
13. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
14. Activation of NRF2 by epiberberine improves oxidative stress and insulin resistance in T2DM mice and IR-HepG2 cells in an AMPK dependent manner.
Zhang S; Zhang S; Zhang Y; Wang H; Chen Y; Lu H
J Ethnopharmacol; 2024 Jun; 327():117931. PubMed ID: 38382657
[TBL] [Abstract][Full Text] [Related]
15. Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells.
Wang ZS; Lu FE; Xu LJ; Dong H
Acta Pharmacol Sin; 2010 May; 31(5):578-84. PubMed ID: 20383171
[TBL] [Abstract][Full Text] [Related]
16. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
[TBL] [Abstract][Full Text] [Related]
17. Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.
Xu J; Zhang Y; Yu Z; Guan Y; Lv Y; Zhang M; Zhang M; Chen L; Lv X; Guan F
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1464-1475. PubMed ID: 36269134
[TBL] [Abstract][Full Text] [Related]
18. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
19. Camel whey protein (CWP) ameliorates liver injury in type 2 diabetes mellitus rats and insulin resistance (IR) in HepG2 cells
Dou Z; Liu C; Feng X; Xie Y; Yue H; Dong J; Zhao Z; Chen G; Yang J
Food Funct; 2022 Jan; 13(1):255-269. PubMed ID: 34897341
[TBL] [Abstract][Full Text] [Related]
20. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
